Search Results

There are 15780 results for: content related to: Clinical–Pathological study of levodopa complications

  1. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease

    Movement Disorders

    Volume 17, Issue 6, November/December 2002, Pages: 1180–1187, Susan H. Fox, Brian Henry, Michael Hill, Alan Crossman and Jonathan Brotchie

    Version of Record online : 25 JUL 2002, DOI: 10.1002/mds.10289

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  5. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  6. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Karla Soares-Weiser, Claire B Irving and John Rathbone

    Published Online : 22 APR 2003, DOI: 10.1002/14651858.CD000208

  7. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  8. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22022

  9. Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1131–1142, Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag and Christopher G. Goetz

    Version of Record online : 22 MAR 2010, DOI: 10.1002/mds.23072

  10. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Hany G El-Sayeh, John Rathbone, Karla Soares-Weiser and Hanna Bergman

    Published Online : 18 JAN 2018, DOI: 10.1002/14651858.CD000458.pub3

  11. Benzodiazepines for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Paranthaman Sethupathi Bhoopathi and Karla Soares-Weiser

    Published Online : 19 JUL 2006, DOI: 10.1002/14651858.CD000205.pub2

  12. The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2084–2093, Tom H. Johnston, Susan H. Fox, Matthew J. Piggott, Juha-Matti Savola and Jonathan M. Brotchie

    Version of Record online : 7 SEP 2010, DOI: 10.1002/mds.23172

  13. Parkinson's disease home diary: Further validation and implications for clinical trials

    Movement Disorders

    Volume 19, Issue 12, December 2004, Pages: 1409–1413, Robert A. Hauser, Frieda Deckers and Philippe Lehert

    Version of Record online : 21 JUL 2004, DOI: 10.1002/mds.20248

  14. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Version of Record online : 27 JAN 2010, DOI: 10.1002/mds.22960

  15. Cholinergic medication for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Irina Tammenmaa, John McGrath, Eila ES Sailas and Karla Soares-Weiser

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD000207

  16. Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials

    European Journal of Neurology

    Volume 21, Issue 3, March 2014, Pages: 433–440, M. Chondrogiorgi, A. Tatsioni, H. Reichmann and S. Konitsiotis

    Version of Record online : 7 DEC 2013, DOI: 10.1111/ene.12318

  17. Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2059–2066, Louisa Clare Johnston, Michael John Jackson, Sarah Rose, Andrew Christopher McCreary and Peter Jenner

    Version of Record online : 18 AUG 2010, DOI: 10.1002/mds.23249

  18. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1064–1071, C. Warren Olanow, Karl Kieburtz, Olivier Rascol, Werner Poewe, Anthony H. Schapira, Murat Emre, Helena Nissinen, Mika Leinonen, Fabrizio Stocchi and for the Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators

    Version of Record online : 29 APR 2013, DOI: 10.1002/mds.25364

  19. Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure

    Movement Disorders

    Volume 18, Issue 5, May 2003, Pages: 487–495, Lance A. Smith, Michael J. Jackson, Matthew J. Hansard, Eleni Maratos and Peter Jenner

    Version of Record online : 28 MAR 2003, DOI: 10.1002/mds.10394

  20. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Version of Record online : 27 JUL 2006, DOI: 10.1002/mds.20936